In support, carvacrol treatment was shown to down-regulate IFN-γ expression in splenocytes of asthmatic mice (Kianmehr et al., 2016) and to decrease IFN-γ and IL-6 secretion in mice suffering from multiple sclerosis (Mahmoodi et al., 2019). The gene discussed is IFNG; the disease is multiple sclerosis.